The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
CD 123 is a membrane biomarker and a therapeutic target in hematologic malignancies
Open accessAbstract
Recent studies indicate that abnormalities of the alpha-chain of the interleukin-3 receptor (IL-3RA or CD123) are frequently observed in some leukemic disorders and may contribute to the proliferative advantage of leukemic cells. This review analyzes the studies indicating that CD123 is overexpressed in various hematologic malignancies, including a part of acute myeloid and B-lymphoid leukemias, blastic plasmocytoid dendritic neoplasms (BPDCN) and hairy cell leukemia.Given the low/absent CD123 expression on normal hematopoietic stem cells, attempts have been made at preclinical first, and then at clinical level to target this receptor. Since the IL-3R is a membrane receptor there are two relatively simple means to target this molecule, either using its natural ligand or neutralizing monoclonal antibodies. Recent reports using a fusion molecule composed by human IL-3 coupled to a truncated diphteria toxin have shown promising antitumor activity in BPDCN and AML patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jordan, C., Upchurch, D., Szilvassy, S., Guzman, M., Howard, D., Pettigrew, A., Meyerrose, T., Rossi, R., Grimes, B., Rizzieri, D., et al. (2000) · Leukemia · doi:10.1038/sj.leu.2401903 · Cited by 821
Characterization of human blood dendritic cell subsets
MacDonald, K. P. A., Munster, D. J., Clark, G. J., Dzionek, A., Schmitz, J., & Hart, D. N. J. (2002) · Blood · doi:10.1182/blood-2001-11-0097 · Cited by 758
Nuclear factor-κB is constitutively activated in primitive human acute myelogenous leukemia cells
Guzman, M. L., Neering, S. J., Upchurch, D., Grimes, B., Howard, D. S., Rizzieri, D. A., Luger, S. M., & Jordan, C. T. (2001) · Blood · doi:10.1182/blood.v98.8.2301 · Cited by 758
Prospective isolation of human clonogenic common myeloid progenitors
Manz, M. G., Miyamoto, T., Akashi, K., & Weissman, I. L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.172384399 · Cited by 534
Jin, L., Lee, E. M., Ramshaw, H. S., Busfield, S. J., Peoppl, A. G., Wilkinson, L., Guthridge, M. A., Thomas, D., Barry, E. F., Boyd, A., et al. (2009) · Cell Stem Cell · doi:10.1016/j.stem.2009.04.018 · Cited by 522
Role for interleukin-3 in mast-cell and basophil development and in immunity to parasites
Lantz, C. S., Boesiger, J., Song, C. H., Mach, N., Kobayashi, T., Mulligan, R. C., Nawa, Y., Dranoff, G., & Galli, S. J. (1998) · Nature · doi:10.1038/32190 · Cited by 474
Dendritic cell ontogeny: A human dendritic cell lineage of myeloid origin
Olweus, J., BitMansour, A., Warnke, R., Thompson, P. A., Carballido, J., Picker, L. J., & Lund-Johansen, F. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.23.12551 · Cited by 470
Rothenberg, M. E., Owen, W. F., Silberstein, D. S., Woods, J., Soberman, R. J., Austen, K. F., & Stevens, R. L. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113547 · Cited by 469
Sawadogo, D., Tolo, A., Kassi, H., Sangare, M., & Inwoley, A. (2013) · Mediterranean Journal of Hematology and Infectious Diseases · doi:10.4084/mjhid.2013.023 · Cited by 381
Identification of a leukemic counterpart of the plasmacytoid dendritic cells
Chaperot, L. (2001) · Blood · doi:10.1182/blood.v97.10.3210 · Cited by 378
Cited by
Advances in acute myeloid leukemia
Newell, L. F., & Cook, R. J. (2021) · BMJ · doi:10.1136/bmj.n2026 · Cited by 440
Tagraxofusp in Blastic Plasmacytoid Dendritic-Cell Neoplasm
Pemmaraju, N., Lane, A. A., Sweet, K. L., Stein, A. S., Vasu, S., Blum, W., Rizzieri, D. A., Wang, E. S., Duvic, M., Sloan, J. M., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1815105 · Cited by 437
Bellavia, D., Raimondo, S., Calabrese, G., Forte, S., Cristaldi, M., Patinella, A., Memeo, L., Manno, M., Raccosta, S., Diana, P., et al. (2017) · Theranostics · doi:10.7150/thno.17092 · Cited by 368
Flotetuzumab as salvage immunotherapy for refractory acute myeloid leukemia
Uy, G. L., Aldoss, I., Foster, M. C., Sayre, P. H., Wieduwilt, M. J., Advani, A. S., Godwin, J. E., Arellano, M. L., Sweet, K. L., Emadi, A., et al. (2021) · Blood · doi:10.1182/blood.2020007732 · Cited by 326
Molecular biomarkers in acute myeloid leukemia
Prada-Arismendy, J., Arroyave, J. C., & Röthlisberger, S. (2017) · Blood Reviews · doi:10.1016/j.blre.2016.08.005 · Cited by 304
Metadata
- Authors
- Testa, U., Pelosi, E., & Frankel, A.
- Venue
- Biomarker Research
- Published
- 2014-02-10
- Volume
- 2
- Issue
- 1
- Pages
- 4-4
- ISSN
- 2050-7771 (ISSN-L)
- OpenAlex
- W2115492737
- Cited by
- 255
- References
- 54
- FWCI
- 9.80
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: CD 123 is a membrane biomarker and a therapeutic target in hematologic malignancies. https://app.cochat.ai/papers/10.1186/2050-7771-2-4
- The paper
- Testa, U., Pelosi, E., & Frankel, A. (2014). CD 123 is a membrane biomarker and a therapeutic target in hematologic malignancies. Biomarker Research. https://doi.org/10.1186/2050-7771-2-4
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.